A Study to Evaluate the Long Term Safety and Tolerability of UTTR1147A in Patients with Moderate to Severe Ulcerative Colitis or Crohn's Disease A Study to Evaluate the Long Term Safety and Tolerability of UTTR1147A in Patients with Moderate to ...
A PHASE II OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLERABILITY OF UTTR1147A IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS OR CROHN'S DISEASE A PHASE II OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLERABILITY OF UTTR1147A ...
A Phase I Study of RO7021610 in Patients with Ulcerative Colitis
A Phase I Multiple-Dose Study of RO7021610 in Japanese Patients with Ulcerative Colitis
Ulcerative colitis
Intervention name : RO7021610 INN of the intervention : Efmarodocokin alfa Dosage And administration of the intervention : RO7021610 will be administrated repeatedly by IV. Control intervention name : Placebo INN of the control intervention : - Dosage And administration of the control intervention : Placebo will be administrated repeatedly by IV. Intervention name : RO7021610 INN of the intervention : Efmarodocokin alfa Dosage And administration o ...
A Study to Evaluate the Long Term Safety and Tolerability of UTTR1147A in Patients with Moderate to Severe Ulcerative Colitis or Crohn's Disease A Study to Evaluate the Long Term Safety and Tolerability of UTTR1147A in Patients with Moderate to ...
A PHASE II OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLERABILITY OF UTTR1147A IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS OR CROHN'S DISEASE A PHASE II OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLERABILITY OF UTTR1147A ...